Home › Funds › Guardian Partners Inc. › ABCL

Guardian Partners Inc. position in ABCL

ABCELLERA BIOLOGICS INC · Health Care

Guardian Partners Inc. reported holding 595,998 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$8.7M, representing 0.77% of its reported portfolio and ranking #40 among its reported holdings. Guardian Partners Inc. has disclosed ABCL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)596.00K sh
Reported value held$8.70M
Portfolio Weight0.77%
First reportedQ4 2024
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Guardian Partners Inc.'s ABCL position evolved

Guardian Partners Inc. first disclosed a stake in ABCL in Q4 2024 at 1,786,414 shares (US$5.4M). The position peaked in Q3 2025 at 1,786,414 shares, worth US$10.6M. Across 8 filings, Guardian Partners Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 595,998 shares valued at US$8.7M. Notable position changes include a 67% trim in Q2 2026 (shares rose 86% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.79M $5.41M New
Q1 2025 1.79M $4.52M Hold
Q2 2025 1.79M $7.54M Hold
Q3 2025 1.79M $10.65M Hold
Q4 2025 1.79M $5.82M Hold
Q1 2026 1.79M $6.25M Hold
Q2 2026 596.00K $4.68M Reduce
Q3 2026 596.00K $8.70M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABCL and 13F data

ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 37 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$32.2M), Intellectus Partners, LLC (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABCL

All ABCL fund holders →

FAQ

How long has Guardian Partners Inc. held ABCL?

Guardian Partners Inc. has disclosed ABCL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Guardian Partners Inc.'s current position in ABCL?

As of Q3 2026, Guardian Partners Inc. holds 596.00K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $8.70M, representing 0.77% of its reported portfolio and ranking #40.

Has Guardian Partners Inc. been buying or selling ABCL?

In the latest 13F filing (Q3 2026), Guardian Partners Inc. held unchanged its position in ABCL. The position peaked in Q3 2025 at 1.79M shares.

Which other funds hold ABCL?

Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, Intellectus Partners, LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.